PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | C0011847|diabetes |
| Sentences | 526 |
| PubMedID- 21331374 | Current recommendations for adults state that the added cardiovascular disease risk associated with diabetes is equivalent to that of a previous myocardial infarction. |
| PubMedID- 25019007 | Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the collaborative atorvastatin diabetes study (cards). |
| PubMedID- 25391871 | Objective: to explore the change and possible role of blood lipids during the course of plaque formation induced by diabetes mellitus in patients with ischemic cerebral vascular disease. |
| PubMedID- 23715361 | The present studies found that microalbuminuria is predictive, independent of classical risk factor of cardiovascular diseases and all causes of mortality in diabetes or hypertension patient groups and in the general population. |
| PubMedID- 24918803 | Interventions targeted at modifiable risk factors, such as smoking cessation and management of hypertension and dyslipidemia, reduce the risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 21998600 | Higher vascular calcification scores were related to older age, diabetes, history of cardiovascular disease (cvd), and lower levels of 25(oh)d5). |
| PubMedID- 23230099 | The macrovascular complications of diabetes, which can lead to cardiovascular diseases, are the major cause of death in patients with type 2 diabetes. |
| PubMedID- 26056618 | Accordingly, we constructed a predictive model for the appearance of cardiovascular diseases in patients with type 2 diabetes admitted via the emergency department. |
| PubMedID- 24757198 | All patients had insulin-treated type 2 diabetes and a history of either cardiovascular disease or two cardiovascular risk factors. |
| PubMedID- 25903071 | Evidence for an excess risk of cardiovascular disease associated with diabetes in women is increasing, an observation that urges intensified treatment and management of female diabetes patients. |
| PubMedID- 24476202 | Participants with type 2 diabetes were free of clinical evidence of cardiovascular disease and renal involvement. |
| PubMedID- 21144031 | Risk factors with weaker and inconsistent associations were gender, ethnicity, diabetes, iris colour, history of cerebrovascular disease, and serum total and hdl cholesterol and triglyceride levels. |
| PubMedID- 24432038 | Aggressive treatment of dyslipidemia will reduce the risk of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 22164268 | Although observational studies have reported a strong association between hyperglycemia and increased risk for cardiovascular disease in individuals with type 2 diabetes, the results of recent interventional randomized controlled trials in establishing the benefit of intensive glycemic control on cardiovascular outcomes have been elusive –. |
| PubMedID- 24708826 | **p-value from adjusted regression model where group was recognised and not recognised; adjusted variables were age, apache ii score, hypertension, diabetes and any type of vascular disease (reduced to two principal components in regression models). |
| PubMedID- 21632491 | Sensitive cardiac troponin t assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the women's health study. |
| PubMedID- 23243415 | Background: diabetes is associated with increased cardiovascular disease, but the underlying cellular and molecular mechanisms are poorly understood. |
| PubMedID- 26243552 | The relative risk of cardiovascular diseases in those with diabetes is approximately twice the level seen in those without diabetes.9 although glycated haemoglobin a1c (hba1c), which was integrated into the diagnostic criteria for diabetes by the american diabetes association in 2010, has been demonstrated to be associated with cardiovascular diseases in observational studies,10 evidence from randomised controlled trials is not consistent regarding hba1c reduction and macrovascular outcomes.1112 moreover, few studies have examined the association between hba1c concentrations and low-grade albuminuria, an early marker of cardiovascular diseases, or compared the associations with low-grade albuminuria among hba1c, fasting plasma glucose (fpg) and 2 h postload glucose (2 h pg). |
| PubMedID- 21108545 | Gestational diabetes mellitus and risk of future maternal cardiovascular disease. |
| PubMedID- 24396696 | Pwv reflects arterial stiffness and is a marker of atherosclerotic vascular disease in patients with diabetes . |
| PubMedID- 23466101 | Objectives: low levels of blood adiponectin contribute to an increased risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 26413719 | We also adjusted for body mass index and comorbidities including hypertension, diabetes mellitus and history of cerebrovascular disease (model 2, table 3). |
| PubMedID- 26491340 | Background: hypertension is a highly prevalent risk factor for cardiovascular disease in patients with type 1 diabetes mellitus. |
| PubMedID- 22247785 | There is solid evidence for an important role for the microcirculation as a possible link between the cardiometabolic risk factors insulin resistance and hypertension, conditions that may further develop into diabetes with subsequent cardiovascular disease. |
| PubMedID- 25885892 | This may be as a direct result of a longer duration of diabetes with more micro-vascular disease and less optimal glycemic status at the start of pregnancy with only 41% having an hba1c <7% in trimester 1. micro-vascular disease has been demonstrated to compromise placental circulation and to increase risk of stillbirth and preeclampsia . |
| PubMedID- 24227183 | Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the swedish national diabetes register. |
| PubMedID- 22419928 | Cardiovascular disease in diabetes mellitus is multi-factorial and risk factors include hypertension, dyslipidaemia, insulin resistance and central obesity 8. |
| PubMedID- 26382729 | Left ventricular mass volume ratio (lvmvr) was significantly higher in the cardiovascular disease group with diabetes compared with the healthy controls but not compared to either of the other two groups. |
| PubMedID- 19925460 | We present a case of brutal diabetes mellitus in a patient with severe vascular disease that underwent a third pancreas transplant. |
| PubMedID- 25014552 | diabetes is strongly associated with cardiovascular disease, but the mechanisms, structural and biomechanical consequences of aberrant blood vessel remodelling remain poorly defined. |
| PubMedID- 24167560 | Model 1: adjusted for age, sex, diabetes mellitus, previous history of cardiovascular disease, smoking, systolic blood pressure, and lipid-lowering agents, and bmi. |
| PubMedID- 24308487 | Prevalence of cardiovascular disease in participants with and without diabetes, born in iraq or sweden. |
| PubMedID- 23294625 | Several potential new biomarkers for cardiovascular diseases in diabetes have appeared during recent years. |
| PubMedID- 25179966 | Peripheral neuropathy may be a potential risk of cardiovascular disease in diabetes mellitus. |
| PubMedID- 22848415 | Adjusted for age, indication, diabetes, history of cardiovascular disease, socio economic position, and >90 sick-leave days in total the year prior to pci. |
| PubMedID- 26339493 | From regression analysis, we found that diabetes, a history of cardiovascular disease and symptoms of shortness of breath determined hrqol (euroqol) more strongly in men than in women. |
| PubMedID- 24686885 | Among those with established diabetes, the risk of cardiovascular disease (cvd) and mortality can be reduced by intensive treatment of single risk factors, including blood pressure, cholesterol, and glucose.3–6 further, a small (n = 160) trial of multifactorial treatment found a protective effect at 13 years.7 screen-detected populations have a cvd risk profile that is distinct from that of individuals with clinically diagnosed or established diabetes,8,9 and evidence to inform the treatment of individuals found earlier in the course of the disease, where cvd risk varies greatly,8 is lacking. |
| PubMedID- 24690919 | Risk factors for cardiovascular disease including diabetes have seen a large rise in prevalence in recent years. |
| PubMedID- 23670279 | Exclusion criteria were a history of respiratory or cardiovascular disease, including diabetes, hypertension, and hypercholesterolemia; symptoms suggesting osa; and taking medication for any of the above-mentioned conditions currently or in the past. |
| PubMedID- 26485682 | Sympathetic abnormalities play an important role in the pathophysiology of cardiovascular disease associated with metabolic syndrome, diabetes mellitus and obesity . |
| PubMedID- 22672997 | Cadjusted for age (categorical), hypertriglyceridemia, hypercholesterolemia, low high-density lipoprotein cholesterol, abdominal obesity, diabetes, hypertension, family history of cardiovascular disease, menopause, current smoking, education, and weight. |
| PubMedID- 20228404 | Background: we investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. |
| PubMedID- 20191077 | Proactive trial36 enrolled 5238 patients with type 2 diabetes who had evidence of macrovascular disease in a prospective, randomized study. |
| PubMedID- 20959955 | Postprandial time did not affect associations between lipid concentrations and cardiovascular disease risk in patients with diabetes, nor did it influence prediction of cardiovascular disease. |
| PubMedID- 22247606 | vascular diseases associated with hypercholesterolemia, diabetes and hypertension are characterized by endothelial dysfunction and reduced endothelium-mediated vasodilation. |
| PubMedID- 24742197 | Multivariable or: adjusted further for age, systolic blood pressure, antihypertensive medication use, body mass index, smoking, alcohol intake, diabetes, history of cardiovascular disease, serum hdl cholesterol, serum triglycerides (tg), serum aspartate aminotransferase (ast), and serum γ-glutamyltranspeptidase (γgtp). |
| PubMedID- 25905182 | Role of glucose and lipids in the cardiovascular disease of patients with diabetes |
| PubMedID- 20195771 | diabetes also is associated with microvascular disease and autonomic neuropathy; and, these non-coronary atherosclerotic pathophysiologic processes also have the potential to increase the risk of sca. |
| PubMedID- 24953607 | Aims: non-alcoholic fatty liver disease and its precursor hepatic steatosis is common in obesity and type-2 diabetes and is associated with cardiovascular disease (cvd). |
| PubMedID- 21647437 | Models are adjusted for age, gender, education level, smoking status, alcohol consumption, medication for hypertension, medication for dyslipidaemia, medication for depression, baseline diabetes status, family history of cardiovascular disease, sleep duration and total physical activity energy expenditure. |